Decitabine for High-Risk Sickle Cell Disease
Clinical trial NCT01375608 · COMPLETED
Trial details
- NCT number
- NCT01375608
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.